Market Overview

MedPharm Holdings Develops Innovative Cannabinoid Infused Dissolvable Oral Strip

Share:

Today MedPharm Holdings announced the successful formulation and
development of micro-emulsified, cannabis infused, dissolvable thin
strips "Melts," powered with their proprietary Lipophilic Enhanced
Absorption Formulation (LEAF) technology. The oral strip is unique in
that it micro encapsulates cannabinoids in a water-soluble delivery
system. This comes on the heels of a major announcement from publicly
traded Medicine Man Technologies (MDCL) to acquire MedPharm Holdings,
LLC.

This press release features multimedia. View the full release here:
https://www.businesswire.com/news/home/20190131005425/en/

Scientists at MedPharm mix cannabinoids to create innovative dosage forms. (Photo: Business Wire)

Scientists at MedPharm mix cannabinoids to create innovative dosage forms. (Photo: Business Wire)

"Melts" is a dissolvable oral thin strip (similar to Listerine
Pocketpaks) that allows for a consistent and exact cannabis dose, which
isn't available through smoking or vaping cannabis directly. When
combined with micro-emulsification of cannabinoids into a water-soluble
substrate, "Melts" also avoids some issues created by oral cannabis
dosing, such as delayed onset, which can lead to users taking too much
cannabis. "Melts" will allow consumers to more easily self-regulate
their dose. "Melts" will be available as both a microdose and a higher
THC dose, with varying ratios of THC, CBD and terpene profiles for
consumer needs.

"Our formulation team, led by Scott Karolchyk, MS, RPh, continues to
come up with new, innovative and effective dosage forms that consumers
appreciate. This is just the beginning, but it showcases the
capabilities of the MedPharm team," Albert Gutierrez, MedPharm CEO,
says. "It also enhances the precision and reproducibility of dosage
forms that we will be able to provide for clinical trials."

MedPharm will deliver a great tasting, rapid-onset product, manufactured
under GMP conditions. This convenient dosage form will be popular with
consumers who want a discreet, but rapid, dose of cannabinoids, allowing
for easier consumption throughout the day. MedPharm plans to begin
production of Melts in Q3 2019, sold in both a single pack and a
multi-pack.

About MedPharm

MedPharm is a phytopharmaceutical and intellectual property holding
company that has been created to develop innovative cannabis products,
using accepted pharmaceutical formulation techniques, to reliably
produce identifiable and replicable dosage forms for human use. MedPharm
leads the industry in developing products to improve the human condition
and better the lives of those who suffer from disease. The MedPharm
facility has the only cannabis research license in the United States.

www.medpharmholdings.com

View Comments and Join the Discussion!
 
Fastest Market News Application
You'll Hear It First On Pro
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com